#41 How to anticoagulate CKD patients with Atrial Fibrilation?, with Frida Welander

Update: 2025-04-10

Description

We’re focusing on a challenging topic: anticoagulation in CKD patients with atrial fibrillation. With up to 25% of CKD patients affected, managing this common arrhythmia is no easy task. How do we balance stroke prevention and bleeding risks? What’s the role of DOACs versus vitamin K antagonists? And should dialysis patients even receive anticoagulation? Are there any new treatment options? To help us untangle these questions, we’re joined by Frida Welander from Karolinska University, Sweden, an expert on the field. Don’t miss this insightful discussion.

Comments

In Channel

Trailer Primary hyperoxaluria type 1, Antibody-mediated rejection treatment – now and in the future and Sustainable nephrology

2025-10-0202:05

#51 Monoclonal gammopathy with renal significance, with Jolanta Małyszko

2025-09-1128:47

#50 Onconephrology: A huge subject, with Kenar D. Jhaveri

2025-09-1115:48

#49 Obesity and CKD, with Marieta Theodorakopoulou

2025-09-1123:17

Trailer Obesity and CKD, Onconephrology: A huge subject and Monoclonal gammopathy with renal significance

2025-09-0401:52

#48 Xenotransplantation: Is it for real? with David Cooper

2025-06-1931:01

#47 Infection prophylaxis for renal transplant recipients in 2025, with Ilaria Gandolfini

2025-06-1928:27

#46 Adapting anti-rejection treatment in a failing renal graft, with Cristophe Mariat

2025-06-1915:43

Trailer Adapting anti-rejection treatment in a failing renal graft, Infection prophylaxis for renal transplant recipients in 2025 and Xenotransplantation: Is it for real?

2025-06-1202:29